Cataract surgery and nonsteroidal antiinflammatory drugs
The following summary from the ESCRS Publications Committee highlights why they consider this a 'Landmark' article.
Nice review of NSAIDs
A review of the use of nonsteroidal inflammatory drugs (NSAIDS) in cataract surgery highlights their potential, whether used alone, or synergistically with steroids, to the potential improve surgical outcomes. The authors not that In addition to their important ability to reduce the incidence of cystoid macular oedema (CME) for specific high-risk eyes prone to the development of the complication, the medications have been found to reduce pain, prevent intraoperative miosis, modulate postoperative inflammation. They add that a thorough understanding of preoperative, intraoperative, and postoperative uses of NSAIDs can help surgeons maximise the therapeutic benefits of the agents.